The trajectory of Viagra, initially marketed by copyright, presents a fascinating case study for stakeholders considering the drug arena . Despite its groundbreaking success and impact of billions in earnings , the intellectual property end has opened the way for alternative medications, significantly diminishing profit opportunities. This change r